A detailed history of Jane Street Group, LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 87,075 shares of HRMY stock, worth $2.97 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
87,075
Previous 111,838 22.14%
Holding current value
$2.97 Million
Previous $3.37 Million 3.08%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$30.0 - $39.95 $742,890 - $989,281
-24,763 Reduced 22.14%
87,075 $3.48 Million
Q2 2024

Aug 14, 2024

BUY
$28.81 - $33.01 $3.22 Million - $3.69 Million
111,838 New
111,838 $3.37 Million
Q4 2023

Feb 14, 2024

SELL
$19.2 - $33.78 $535,257 - $941,718
-27,878 Reduced 31.06%
61,869 $2 Million
Q3 2023

Nov 14, 2023

BUY
$31.89 - $39.03 $2.21 Million - $2.71 Million
69,352 Added 340.04%
89,747 $2.94 Million
Q2 2023

Aug 14, 2023

SELL
$30.5 - $37.4 $1.73 Million - $2.12 Million
-56,645 Reduced 73.53%
20,395 $717,000
Q1 2023

May 15, 2023

BUY
$30.8 - $53.92 $2.24 Million - $3.92 Million
72,626 Added 1645.36%
77,040 $2.52 Million
Q4 2022

Feb 14, 2023

SELL
$45.4 - $60.91 $391,166 - $524,800
-8,616 Reduced 66.12%
4,414 $243,000
Q3 2022

Nov 14, 2022

BUY
$42.06 - $55.45 $288,363 - $380,165
6,856 Added 111.05%
13,030 $577,000
Q3 2022

Nov 14, 2022

BUY
$42.06 - $55.45 $288,363 - $380,165
6,856 Added 111.05%
13,030 $577,000
Q2 2022

Aug 16, 2022

SELL
$33.54 - $52.15 $379,806 - $590,546
-11,324 Reduced 64.72%
6,174 $301,000
Q1 2022

May 17, 2022

BUY
$33.14 - $51.13 $579,883 - $894,672
17,498 New
17,498 $851,000

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.02B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.